A Single‐Atom Mn/MoO 3− x Nanoagonist for Cascade cGAS/STING Activation in Tumor‐Specific Catalytic Metalloimmunotherapy
Small · 2025
DOI: 10.1002/smll.202407214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Xi Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Anhui University of Chinese Medicine, Hef…. Hauptthemen laut MEDLINE: Molybdenum, Manganese, Nucleotidyltransferases, Membrane Proteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Leading Talent of "Ten Thousand Plan"-National High-Level Talents Special Support Plan.
Abstract (Originalsprache)
The cyclic GMP‐AMP synthase (cGAS)/stimulator of interferon genes (STING) pathway plays a crucial role in initiating anti‐tumor immunity. Despite the development of various STING agonists, their effectiveness is often limited by suboptimal activation efficiency and poor sustainability. To address this, a Mn/MoO 3− x nanoagonist featuring Mn single‐atom sites is presented, designed for cascade cGAS/STING activation in tumor‐specific catalytic metalloimmunotherapy. The single‐atom nanoagonist (SANA) is meticulously crafted by doping Mn atoms into defective molybdenum oxide (MoO 3− x ), enabling robust peroxidase‐mimicking catalysis and inducing severe double‐stranded DNA (dsDNA) damage in tumors. Of note, Mn 2+ and MoO 4 2− can be responsively released from Mn/MoO 3− x SANA and enhance the sensitivity of cGAS to dsDNA. Importantly, MoO 4 2− with a relatively slow‐release profile and facile cellular accumulation compensates for Mn 2+ that has poor cellular accumulation due to continuous efflux, thus continuatively triggering the secretion of type I interferon for beyond 72 h. Remarkably, Mn/MoO 3− x SANA significantly inhibits tumor growth and metastasis without supplementary STING agonists or external stimulation. This study offers a promising cascade cGAS/STING activation approach to enhance the efficacy and sustainability of catalytic metalloimmunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Anhui University of Chinese Medicine, Hefei, Anhui, 230038, China.
- Institute of Pharmaceutics, Anhui Academy of Chinese Medicine, Hefei, Anhui, 230038, China.
- Institute of Pharmaceutics, Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
- Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, National Center for Translational Medicine, Shanghai Jiao Tong University, Shanghai, 200240, China.
- WLA Laboratories, Shanghai, 201203, China.
- Department of Clinical Laboratory, Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders (LEAD), Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Sha…
ORCID-Profile: Daishun Ling
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Leading Talent of "Ten Thousand Plan"-National High-Level Talents Special Support Plan
- Anzhong Scholars Outstanding Talents Plan
- University Excellent Youth Scientific Research Project of Anhui Province
- Program of Shanghai Academic Research Leader under the Science and Technology Innovation Action Plan
- Program of Shanghai Science and Technology Development
- Shanghai Municipal Health Commission Traditional Chinese Medicine Research Project
Zitieren
APA
Hu, X., Ma, Z., Zhang, B., Wang, J., Zhou, Y., Li, J., Liu, T., Zhang, J., Hong, B., Zhu, M., Li, F., & Ling, D. (2025). A Single‐Atom Mn/MoO 3− x Nanoagonist for Cascade cGAS/STING Activation in Tumor‐Specific Catalytic Metalloimmunotherapy. Small. https://doi.org/10.1002/smll.202407214
Vancouver
Hu X, Ma Z, Zhang B, Wang J, Zhou Y, Li J, et al. A Single‐Atom Mn/MoO 3− x Nanoagonist for Cascade cGAS/STING Activation in Tumor‐Specific Catalytic Metalloimmunotherapy. Small. 2025. doi:10.1002/smll.202407214
BibTeX
@article{Hu2025,
author = {Hu, Xi and Ma, Zhiyuan and Zhang, Bo and Wang, Jie and Zhou, Yan and Li, Jun and Liu, Tianqi and Zhang, Jingxin and Hong, Bangzhen and Zhu, Mingjian and Li, Fangyuan and Ling, Daishun},
title = {A Single‐Atom Mn/MoO 3− x Nanoagonist for Cascade cGAS/STING Activation in Tumor‐Specific Catalytic Metalloimmunotherapy},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202407214}
}
EUVIMED